(Q35229878)

7 August 2017

1 reference

title

Clinical effects and mechanism of action of sumatriptan in migraine (English)

1 reference

7 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

6 December 2023

1

Ferrari MD

1 reference

7 August 2017

P. R. Saxena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320526

13 September 2022

M. D. Ferrari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320526

6 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1320526

13 September 2022

publication date

1 January 1992

1 reference

full work available at URL

7 August 2017

https://api.elsevier.com/content/article/PII:0303846792900282?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

https://api.elsevier.com/content/article/PII:0303846792900282?httpAccept=text/plain

6 December 2023

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Clinical Neurology and Neurosurgery

6 December 2023

published in

1 reference

7 August 2017

volume

94 Suppl

1 reference

7 August 2017

page(s)

S73-7

1 reference

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

7 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Oral sumatriptan in acute migraine

6 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

6 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group

6 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group

6 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Treatment of Acute Cluster Headache with Sumatriptan

6 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

6 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

6 December 2023

10

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Cortical spreading depression as a putative migraine mechanism

6 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Arterial stenosis in migraine: spasm or arteriopathy?

6 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study.

6 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The safety and tolerability of sumatriptan: an overview

6 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Plasma Serotonin in Migraine and Stress

6 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The effects of reserpine injection on methysergide treated control and migrainous subjects.

6 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Effect of serotonin in migraine patients

6 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Early clinical experience with subcutaneous GR43175 in acute migraine: an overview.

6 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Lack of antinociceptive activity of sumatriptan in rodents

6 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig.

6 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

6 December 2023

Serotonin and migraine

23

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

5-HT receptors in human and animal cerebrovasculature

6 December 2023

24

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Cerebral circulatory and metabolic effects of 5-hydroxytryptamine in anesthetized baboons

6 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist

6 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

International journal of microcirculation, clinical and experimental

6 December 2023

28

9

227

Parsons

1990

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries.

6 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

6 December 2023

30

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs

6 December 2023

32

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175.

6 December 2023

33

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan

6 December 2023

34

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

6 December 2023

35

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

5-HT1-like receptor agonists and the pathophysiology of migraine

6 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus

6 December 2023

43

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

6 December 2023

44

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine

6 December 2023

45

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

6 December 2023

47

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Extracranial vascular changes and the source of pain in migraine headache

6 December 2023

48

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

6 December 2023

49

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches

6 December 2023

50

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

6 December 2023

51

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

6 December 2023

52

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

6 December 2023

53

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy

6 December 2023

55

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites

6 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

GR 43175: A preferential 5-HT1D agent in monkey and human brains as shown by autoradiography

6 December 2023

57

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.

6 December 2023

59

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography

6 December 2023

60

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Identification of 5-hydroxytryptamine1D binding sites in human brain membranes

6 December 2023

61

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype.

6 December 2023

62

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

6 December 2023

64

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites

6 December 2023

67

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein

6 December 2023

69

1 reference

https://api.crossref.org/works/10.1016/0303-8467(92)90028-2

6 December 2023

Identifiers

1 reference

7 August 2017

1 reference